Zucero is an Australian-based biotechnology company focussed on the development of pixatimod, an immunotherapy for the treatment of cancer. Pixatimod successfully completed safety evaluation in a Phase 1a clinical trial. It is currently under investigation in a Phase 1b study in combination with O...See more
Headquarters:
Australia
Company Type:
MNC / Large Enterprise
Company size:
1-10 Employees
Year Founded:
2016 (10 years)
Address:
1 WESTLINK COURT; SUITE 1.11, LEVEL 1; DARRA, QUEENSLAND 4076, AU
LOW
spending power